Bastos et al., 2019 - Google Patents
Comparison of the co-amorphization ability of olanzapine with amino, carboxylic and sulfonic acidsBastos et al., 2019
View PDF- Document ID
- 18351076744556580845
- Author
- Bastos A
- Costa N
- Fernandes A
- Pinto J
- Publication year
- Publication venue
- 3rd European Conference on Pharmaceutics
External Links
Snippet
A large number of active pharmaceutical compounds currently under development are poorly water soluble, a characteristic which can limit their bioavailability and result in formulation challenges1, 2. Strategies to address the problem encompass the conversion of …
- 238000005280 amorphization 0 title abstract description 6
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Patterson et al. | The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds | |
| JP5058151B2 (en) | Crystalline form of asenapine maleate | |
| MX2010010024A (en) | Substituted heterocycle fused gamma-carbolines solid. | |
| KR20100014854A (en) | Solid forms of pemetrexed | |
| WO2018148961A1 (en) | Crystal form of acp-196 salt and preparation method, pharmaceutical composition, and use thereof | |
| RU2613555C2 (en) | Monohydrate crystal of fimasartan potassium salt, method for preparing same, and pharmacological composition comprising same | |
| CN102924434B (en) | Dexrabeprazole sodium monohydrate crystal form and preparation method thereof | |
| Arabiani et al. | Mechanochemical synthesis of brexpiprazole cocrystals to improve its pharmaceutical attributes | |
| SK1912002A3 (en) | Torsemide polymorphs | |
| Setyawan et al. | Co-crystalization of quercetin and malonic acid using solvent-drop grinding method | |
| TWI341731B (en) | Process of lyophilization for the preparation of piroxicam: β-cyclodextrin inclusion compound | |
| Bastos et al. | Comparison of the co-amorphization ability of olanzapine with amino, carboxylic and sulfonic acids | |
| US20070259885A1 (en) | Novel Crystal Form of(3-Cyano-1H-Indol-7-Yl)-[4-(4-Fluorophenethyl)Piperazin-1-Yl] Methanone, Hydrochloride | |
| RU2012127085A (en) | CRYSTAL FORMS III AND IV OF N-BENZOILSTAUROSPORIN | |
| JP2020534331A (en) | ((1S, 2S, 4R) -4- {4-[(1S) -2,3-dihydro-1H-inden-1-ylamino] -7H-pyrrolo [2,3-D] pyrimidin-7-yl} -2-Hydroxycyclopentyl) Co-crystal form of methyl sulfamate, its formulation and use | |
| AU2008259521A1 (en) | Crystalline form B of olmesartan medoxomil | |
| JP5744017B2 (en) | Crystals of thienopyrimidine derivatives | |
| JP2012511006A (en) | Novel crystalline polymorphs of azabicyclo-trifluoromethylbenzamide derivatives | |
| AU2017341088A1 (en) | Crystalline polymorphs of a muscarinic acetylcholine receptor agonist | |
| Balakrishnaiah et al. | Enhancement of solubility and dissolution rate of olmesartan medoxomil by solvent evaporation technique | |
| KR20150079043A (en) | Process for Preparation and Conversion of Taltirelin Crystalline Form α | |
| KR20170060035A (en) | L-proline compound of sodium-glucose cotransporter 2 inhibitor, and monohydrate and crystal of l-proline compound | |
| Chen et al. | A potential cocrystal strategy to tailor in-vitro dissolution and improve Caco-2 permeability and oral bioavailability of berberine | |
| WO2008093350A1 (en) | Novel anhydrous crystalline form of carvedilol dihydrogen phosphate | |
| JP6656505B2 (en) | Orbit azine-fumarate, hydrate, crystal form and method for preparing the same |